PeptideDB

Triazabicyclodecene 5807-14-7

Triazabicyclodecene 5807-14-7

CAS No.: 5807-14-7

Triazabicyclodecene is a biochemical compound that may be utilized as a biomaterial or organic/chemical reagent in biome
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Triazabicyclodecene is a biochemical compound that may be utilized as a biomaterial or organic/chemical reagent in biomedical research.

Physicochemical Properties


Molecular Formula C7H13N3
Molecular Weight 139.20
Exact Mass 139.11
CAS # 5807-14-7
PubChem CID 79873
Appearance Off-white to light yellow solid powder
Density 1.3±0.1 g/cm3
Boiling Point 222.3±23.0 °C at 760 mmHg
Melting Point 125-130 °C(lit.)
Flash Point 88.3±22.6 °C
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.656
LogP -1.08
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 1
Rotatable Bond Count 0
Heavy Atom Count 10
Complexity 153
Defined Atom Stereocenter Count 0
SMILES

C1CNC2=NCCCN2C1

InChi Key FVKFHMNJTHKMRX-UHFFFAOYSA-N
InChi Code

InChI=1S/C7H13N3/c1-3-8-7-9-4-2-6-10(7)5-1/h1-6H2,(H,8,9)
Chemical Name

3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-a]pyrimidine
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Additional Infomation 3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-a]pyrimidine is a member of pyrimidines.

Solubility Data


Solubility (In Vitro) DMSO: 100 mg/mL (718.39 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (17.96 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (17.96 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 7.1839 mL 35.9195 mL 71.8391 mL
5 mM 1.4368 mL 7.1839 mL 14.3678 mL
10 mM 0.7184 mL 3.5920 mL 7.1839 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.